Katalognummer: 870 - ABC-TC3732
Produktkategori: Företag och industri > Vetenskap och laboratorium
Storlek: 1 vial
ABC-TC3732
Human Oligodendrocyte Progenitor Cells can be used for a variety of research applications including studies of neurotoxicity, co- culture applications and screening for molecules that induce or inhibit preferential differentiation to mature oligodendrocytes.
ABC-TC4129
Rat endothelial progenitor cells, 5-week Wistar rat
ABC-SC0092T
Cells expressing the CD133 (AC133, Prominin-1) marker are generally known as primitive hematopoietic stem and progenitor cells (HSC and HPC). While cells expressing the CD133 marker are usually undifferentiated embryonic stem cell lines, this cell type is usually harvested from bone marrow and cord blood but can be also found in multiple locations including the liver, muscle, prostate, kidney, and neural tissue. CD133 stem cells appear to be ancestral to the CD34+ stem cell line due to their ability to differentiate into CD34+ cells and also their higher level of proliferation activity.Capable of a high level of proliferation and a wide range of differentiation, transplantation of CD133+ cell lines has been shown to not only induced multilineage human hematopoiesis through the CD34+ lineage, but also induce regeneration of cell lines in vitro in multiple locations by differentiating into endothelial cells, neural cells, hepatocytes, osteoblasts, and myocytes, with the list of tissue types this cell can differentiate into gradually increasing.CD133+ stem cells are isolated using positive immunomagnetic cell separation procedures from a mobilized leukapheresis collection.
ABC-SC0089T
CD34+ stem cells are multipotent and can give rise to all cell types in blood. CD34 cells are most known for its expression on hematopoietic progenitor cells found in bone marrow and cord blood. While compromising only 1.5% of bone marrow mononuclear cell population, CD34 stem cells are responsible for all lymphohematopoietic lineages and are now commonly used clinically as they have been shown to provide long-term durable donor-derived host lymphohematopoietic reconstitution.Donors are injected with G-CSF, which stimulates the bone marrow to produce a large number of hematopoietic and progenitor stem cells and mobilizes them into the peripheral blood stream.CD34+ cells are isolated using positive immunomagnetic cell separation procedures from a mobilized leukapheresis collection.